PMC:7274950 / 4751-5069 JSONTXT

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T87","span":{"begin":47,"end":53},"obj":"UBERON:0001005"},{"id":"T88","span":{"begin":99,"end":103},"obj":"UBERON:0002048"},{"id":"T89","span":{"begin":152,"end":158},"obj":"UBERON:0001005"},{"id":"T90","span":{"begin":176,"end":182},"obj":"UBERON:0001005"},{"id":"T91","span":{"begin":220,"end":237},"obj":"CHEBI:24402;CHEBI:24402"},{"id":"T92","span":{"begin":257,"end":263},"obj":"UBERON:0001005"},{"id":"T93","span":{"begin":264,"end":274},"obj":"UBERON:0000483;CL:0000066"},{"id":"T94","span":{"begin":279,"end":292},"obj":"UBERON:0001135;CL:0000192"},{"id":"T95","span":{"begin":293,"end":298},"obj":"CL:0000192"},{"id":"T26789","span":{"begin":47,"end":53},"obj":"UBERON:0001005"},{"id":"T26506","span":{"begin":99,"end":103},"obj":"UBERON:0002048"},{"id":"T8053","span":{"begin":152,"end":158},"obj":"UBERON:0001005"},{"id":"T79832","span":{"begin":176,"end":182},"obj":"UBERON:0001005"},{"id":"T78838","span":{"begin":220,"end":237},"obj":"CHEBI:24402;CHEBI:24402"},{"id":"T43574","span":{"begin":257,"end":263},"obj":"UBERON:0001005"},{"id":"T23483","span":{"begin":264,"end":274},"obj":"UBERON:0000483;CL:0000066"},{"id":"T67279","span":{"begin":279,"end":292},"obj":"UBERON:0001135;CL:0000192"},{"id":"T69043","span":{"begin":293,"end":298},"obj":"CL:0000192"}],"text":"The proposed mechanisms for the development of airway obstruction in Fabry disease include loss of lung elastic recoil, hyperreactivity (bronchospasm), airway inflammation and airway narrowing related to accumulation of glycosphingolipid and hyperplasia in airway epithelial and smooth muscle cells [[11], [12], [13]]."}

{"project":"LitCovid-PubTator","denotations":[{"id":"143","span":{"begin":47,"end":65},"obj":"Disease"},{"id":"144","span":{"begin":69,"end":82},"obj":"Disease"},{"id":"145","span":{"begin":91,"end":103},"obj":"Disease"},{"id":"146","span":{"begin":137,"end":149},"obj":"Disease"},{"id":"147","span":{"begin":159,"end":171},"obj":"Disease"},{"id":"148","span":{"begin":220,"end":253},"obj":"Disease"}],"attributes":[{"id":"A143","pred":"tao:has_database_id","subj":"143","obj":"MESH:D000402"},{"id":"A144","pred":"tao:has_database_id","subj":"144","obj":"MESH:D000795"},{"id":"A145","pred":"tao:has_database_id","subj":"145","obj":"MESH:D008171"},{"id":"A146","pred":"tao:has_database_id","subj":"146","obj":"MESH:D001986"},{"id":"A147","pred":"tao:has_database_id","subj":"147","obj":"MESH:D007249"},{"id":"A148","pred":"tao:has_database_id","subj":"148","obj":"MESH:D006965"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"The proposed mechanisms for the development of airway obstruction in Fabry disease include loss of lung elastic recoil, hyperreactivity (bronchospasm), airway inflammation and airway narrowing related to accumulation of glycosphingolipid and hyperplasia in airway epithelial and smooth muscle cells [[11], [12], [13]]."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T41","span":{"begin":99,"end":103},"obj":"Body_part"},{"id":"T42","span":{"begin":220,"end":237},"obj":"Body_part"},{"id":"T43","span":{"begin":279,"end":298},"obj":"Body_part"},{"id":"T44","span":{"begin":293,"end":298},"obj":"Body_part"}],"attributes":[{"id":"A41","pred":"fma_id","subj":"T41","obj":"http://purl.org/sig/ont/fma/fma7195"},{"id":"A42","pred":"fma_id","subj":"T42","obj":"http://purl.org/sig/ont/fma/fma82814"},{"id":"A43","pred":"fma_id","subj":"T43","obj":"http://purl.org/sig/ont/fma/fma14072"},{"id":"A44","pred":"fma_id","subj":"T44","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"The proposed mechanisms for the development of airway obstruction in Fabry disease include loss of lung elastic recoil, hyperreactivity (bronchospasm), airway inflammation and airway narrowing related to accumulation of glycosphingolipid and hyperplasia in airway epithelial and smooth muscle cells [[11], [12], [13]]."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T20","span":{"begin":99,"end":103},"obj":"Body_part"}],"attributes":[{"id":"A20","pred":"uberon_id","subj":"T20","obj":"http://purl.obolibrary.org/obo/UBERON_0002048"}],"text":"The proposed mechanisms for the development of airway obstruction in Fabry disease include loss of lung elastic recoil, hyperreactivity (bronchospasm), airway inflammation and airway narrowing related to accumulation of glycosphingolipid and hyperplasia in airway epithelial and smooth muscle cells [[11], [12], [13]]."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T36","span":{"begin":69,"end":82},"obj":"Disease"},{"id":"T37","span":{"begin":137,"end":149},"obj":"Disease"},{"id":"T38","span":{"begin":159,"end":171},"obj":"Disease"},{"id":"T39","span":{"begin":242,"end":253},"obj":"Disease"}],"attributes":[{"id":"A36","pred":"mondo_id","subj":"T36","obj":"http://purl.obolibrary.org/obo/MONDO_0010526"},{"id":"A37","pred":"mondo_id","subj":"T37","obj":"http://purl.obolibrary.org/obo/MONDO_0001358"},{"id":"A38","pred":"mondo_id","subj":"T38","obj":"http://purl.obolibrary.org/obo/MONDO_0021166"},{"id":"A39","pred":"mondo_id","subj":"T39","obj":"http://purl.obolibrary.org/obo/MONDO_0005043"}],"text":"The proposed mechanisms for the development of airway obstruction in Fabry disease include loss of lung elastic recoil, hyperreactivity (bronchospasm), airway inflammation and airway narrowing related to accumulation of glycosphingolipid and hyperplasia in airway epithelial and smooth muscle cells [[11], [12], [13]]."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T59","span":{"begin":47,"end":53},"obj":"http://purl.obolibrary.org/obo/UBERON_0001005"},{"id":"T60","span":{"begin":99,"end":103},"obj":"http://purl.obolibrary.org/obo/UBERON_0002048"},{"id":"T61","span":{"begin":99,"end":103},"obj":"http://www.ebi.ac.uk/efo/EFO_0000934"},{"id":"T62","span":{"begin":152,"end":158},"obj":"http://purl.obolibrary.org/obo/UBERON_0001005"},{"id":"T63","span":{"begin":176,"end":182},"obj":"http://purl.obolibrary.org/obo/UBERON_0001005"},{"id":"T64","span":{"begin":257,"end":263},"obj":"http://purl.obolibrary.org/obo/UBERON_0001005"},{"id":"T65","span":{"begin":264,"end":274},"obj":"http://purl.obolibrary.org/obo/CL_0000066"},{"id":"T66","span":{"begin":279,"end":298},"obj":"http://purl.obolibrary.org/obo/CL_0000192"},{"id":"T67","span":{"begin":301,"end":303},"obj":"http://purl.obolibrary.org/obo/CLO_0053733"}],"text":"The proposed mechanisms for the development of airway obstruction in Fabry disease include loss of lung elastic recoil, hyperreactivity (bronchospasm), airway inflammation and airway narrowing related to accumulation of glycosphingolipid and hyperplasia in airway epithelial and smooth muscle cells [[11], [12], [13]]."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T17","span":{"begin":220,"end":237},"obj":"Chemical"}],"attributes":[{"id":"A17","pred":"chebi_id","subj":"T17","obj":"http://purl.obolibrary.org/obo/CHEBI_24402"}],"text":"The proposed mechanisms for the development of airway obstruction in Fabry disease include loss of lung elastic recoil, hyperreactivity (bronchospasm), airway inflammation and airway narrowing related to accumulation of glycosphingolipid and hyperplasia in airway epithelial and smooth muscle cells [[11], [12], [13]]."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T25","span":{"begin":137,"end":149},"obj":"Phenotype"}],"attributes":[{"id":"A25","pred":"hp_id","subj":"T25","obj":"http://purl.obolibrary.org/obo/HP_0025428"}],"text":"The proposed mechanisms for the development of airway obstruction in Fabry disease include loss of lung elastic recoil, hyperreactivity (bronchospasm), airway inflammation and airway narrowing related to accumulation of glycosphingolipid and hyperplasia in airway epithelial and smooth muscle cells [[11], [12], [13]]."}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T3","span":{"begin":159,"end":171},"obj":"http://purl.obolibrary.org/obo/GO_0006954"}],"text":"The proposed mechanisms for the development of airway obstruction in Fabry disease include loss of lung elastic recoil, hyperreactivity (bronchospasm), airway inflammation and airway narrowing related to accumulation of glycosphingolipid and hyperplasia in airway epithelial and smooth muscle cells [[11], [12], [13]]."}

{"project":"LitCovid-sentences","denotations":[{"id":"T35","span":{"begin":0,"end":318},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The proposed mechanisms for the development of airway obstruction in Fabry disease include loss of lung elastic recoil, hyperreactivity (bronchospasm), airway inflammation and airway narrowing related to accumulation of glycosphingolipid and hyperplasia in airway epithelial and smooth muscle cells [[11], [12], [13]]."}